BSE filing, NSE: GPTHEALTH. Summary written from the filing by ALFA Finder's alert engine.
GPT Healthcare Ltd: key numbers
- Share price
- ₹132.68
- Market cap
- ₹1,089 Cr
- Revenue (annual)
- ₹472.6 Cr
- Net profit (annual)
- ₹42.22 Cr
- P/E (TTM)
- 23.0×Sector 52.8×
- Promoter holding
- 65.57%+0.00% QoQ
- FII holding
- 3.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GPT Healthcare Ltd
All →GPT Healthcare Board Meeting Date
GPT Healthcare will hold a board meeting on 05 Nov 2026 to consider Q2 and half-year unaudited results and a possible interim dividend for FY 2026-27. Trading window stays closed until 07 Nov 2026.
GPT Healthcare Annual General Meeting
GPT Healthcare Limited held its 37th Annual General Meeting on August 6, 2026. Shareholders transacted ordinary and special business items as stated in the notice.
GPT Healthcare Earnings Call Transcript: Key Takeaways
GPT Healthcare shows strong 18.2% revenue growth and 66% PAT growth, but struggles with utilization outside its core Kolkata market.
GPT Healthcare Results Update
GPT Healthcare reported Q1 FY27 financial results. Total income grew 18% year-over-year to ₹128.2 Crore, reflecting steady operational performance.
GPT Healthcare Investor Presentation: Key Takeaways
GPT Healthcare reported Q1FY27 revenue of ₹126.2 Cr, up 17.8% YoY, with EBITDA margins improving to 20.4%. The company is executing a proximity-based model in Eastern India.
GPT Healthcare Q1 FY27 Results: Net Profit ₹12.7 Cr, Up 64.9% YoY
GPT Healthcare Ltd reported revenue from operations of ₹126.2 Cr (+17.8% YoY) and net profit of ₹12.7 Cr (+64.9% YoY) for Q1 FY27.
- Key figure
- Net profit ₹12.7 Cr · +64.9% YoY
Other other announcement announcements
All →Usha Martin Other Announcement
Usha Martin disclosed a voluntary ESG rating of 69.57 assigned by Niche99, a SEBI-registered ESG Rating Provider, based on FY 2025-26 public data. The company did not engage the provider and the rating was not commissioned.
Robokidz Eduventures Other Announcement
Robokidz Eduventures filed its quarterly shareholding pattern for the period ended 30 September 2026. This is routine SEBI Regulation 31 disclosure with no transaction or corporate event.
Natco Pharma Other Announcement
Natco Pharma filed its shareholding pattern with a reporting date of 23 October 2026. Promoter and promoter group hold about 46% of total equity.
Innomet Advanced Materials Other Announcement
Innomet Advanced Materials filed its half-year Reg 32 statement on preferential issue proceeds, with no deviation. Rs.753.25 lakh raised in August 2026 was fully used for working capital.
CCME Global Other Announcement
CCME Global disclosed insider trades by two connected persons, acquiring 90 lakh and 22.5 lakh shares on 28 October 2026. Combined consideration is stated as Rs.112.50 Crore.
- Value
- ₹112.5 Cr
Jay Jalaram Technologies Other Announcement
Jay Jalaram Technologies named its KMP as authorised persons for materiality determination under Regulation 30. This administrative listing carries no financial or business impact.